Eupraxia Pharmaceuticals EPRX
$5.80 −$0.32 (-5.23%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.80 0.00%
Open$6.11
Prev close$6.12
Day range$5.69 – $6.42
Volume361.7K
Market cap$390.16M
P/E (TTM)–
Dividend yield–
EPRX Stock News
Headlines matching Eupraxia Pharmaceuticals or the EPRX ticker, most recent first.
- Stifel Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $25
- Wedbush Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $17
- H.C. Wainwright Keeps Their Buy Rating on Eupraxia Pharmaceuticals (EPRX)
- H.C. Wainwright Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $11
- William Blair Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating
- LifeSci Capital Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $16
- A Quick Look at Today's Ratings for Eupraxia Pharmaceuticals(EPRX.US), With a Forecast Between $11 to $25
- Cantor Fitzgerald Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $19
- Oppenheimer Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $17
- Oppenheimer Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $17
- Craig-Hallum Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $14
- H.C. Wainwright Remains a Buy on Eupraxia Pharmaceuticals (EPRX)
- Stifel Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $25
- William Blair Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $14
- H.C. Wainwright Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Cuts Target Price to $11 Negative
No comments yet — be the first to weigh in on EPRX.
Sign in to join the discussion.